Company Overview of Jamjoom Pharma
Jamjoom Pharma manufactures and markets pharmaceutical products, over the counter (OTC) medicines, and health related consumer products. The company offers ophthalmology, derma, infection, gastrointestinal, cardiovascular, and general medicine products. Its markets its products under Aciloc, Amvasc, Azi-Once, Ciproxen, Duracan, Elica, Elicasal, Fixit, Hyfresh, Loxtra, Momenta, Tymer, and Xolamol brand names. Jamjoom Pharma was founded in 2000 and is based in Jeddah, Saudi Arabia. The company operates as a subsidiary of The Jamjoom Group.
Founded in 2000
966 12 614 0099
966 12 614 0088
Key Executives for Jamjoom Pharma
Similar Private Companies By Industry
|CAD Middle East Pharmaceutical Industries LLC||Middle East/Africa|
|Glaxo Saudi Arabia Limited||Middle East/Africa|
|Jeddah Bioscan||Middle East/Africa|
|Medical and Cosmetic Products Co. Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Jamjoom Pharma, please visit www.jamjoompharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.